114 results
Page 3 of 6
6-K/A
EX-99.5
eylz9q54 gt
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
EX-99.2
35ot no9bp7ofhexv1m
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.5
iuts25 yi19vfsyldna
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.2
rcv frzo92
5 Aug 21
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
EX-99.1
pngljiswa4sptj2
27 Jul 21
Current report (foreign)
6:12am
6-K
EX-99.2
upkyq0
1 Jun 21
ObsEva SA Announces that Shareholders Approved all Board Proposals at its
6:30am
6-K
EX-99.1
v1gq2jjd4m
20 May 21
ObsEva Announces Final Results from the Phase 3 PRIMROSE Program of
6:30am
6-K
EX-99.1
xzbcbys4 hv
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-99.2
ru3tgni2bpo66luydex
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-99.3
22vn178yi567b9a5c0m
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-99.1
pmh41
31 Mar 21
Current report (foreign)
7:15am
6-K
EX-1.1
4qslov4vxhmgp
5 Mar 21
Current report (foreign)
8:15am
424B5
l0hk5ud2
5 Mar 21
Prospectus supplement for primary offering
7:55am
6-K
EX-99.1
5554v giluz3hk
5 Mar 21
ObsEva Announces Year End 2020 Financial Results
7:21am
6-K
EX-99.2
n6qouvovl8n
17 Feb 21
ObsEva to Present at the SVB Leerink 10th Annual Global Healthcare Conference
6:04am
6-K
EX-99.1
64iq4
10 Feb 21
ObsEva Provides Business Outlook for 2021
6:10am
6-K/A
EX-99.1
9324 9mgxae9
19 Jan 21
Current report (foreign) (amended)
6:25am